Skip to content

Evaluation of Resection Techniques for Pancreatic Tumors

Evaluation of Resection Techniques for Pancreatic Tumors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05128890
Enrollment
431
Registered
2021-11-22
Start date
2016-04-16
Completion date
2027-04-26
Last updated
2026-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Tumor, Pancreas Tumor, Surgery

Brief summary

The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint. The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.

Detailed description

The plan is to conduct a retrospective chart review of patients who have undergone pancreatic and liver resection by using Meditech and Epic. A non-identified database will be created after retrospectively reviewing each patient case involving pancreatic or liver resection at MDMC. The study period will start in January 2006 until December 2020. Variables will include demographics, clinical disease diagnoses, and operative parameters as well as indirect charges from the hospitalizations.

Interventions

PROCEDUREResection techniques for pancreatic and liver tumors

to compare open versus minimally invasive pancreatic resection techniques and analyze the different outcome variables from the clinical standpoint

Sponsors

Methodist Health System
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC) * Patients 18 years old or older

Exclusion criteria

* Patients that have not undergone pancreatic resection surgeries * Patients under 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Patient Survivalthrough study completion, an average of 1 yearIt will be calculated in days.Minimally invasive techniques are being adopted for complex pancreatic and liver surgery and there is a need to understand if these techniques are advantageous to the patient, if the cost is justified and if the risks are acceptable when compared to the gold standard open surgery.
Length of stayUp to 1 yearIt will be calculated in days. The days stayed in hospital post-procedure.
Complication ratesthrough study completion, an average of 1 yearPatient may visit physician or hospital for any symptoms or may need hospitalizations.
Operative timeup to 10 hoursThe time required for the procedure.
Transfusion ratethrough study completion, an average of 1 yearIf any post-procedure transfusion required, will be recorded.
30 and 90 day readmission ratethrough study completion, an average of 1 yearAfter the procedure any hospital admissions up to 30 days will be recorded.
Hospital chargesthrough study completion, an average of 1 yearThe hospital charges for the procedure will be recorded.

Countries

United States

Contacts

CONTACTColette N Ndjom, MS
ClinicalResearch@mhd.com214-947-4681
CONTACTJennifer Kirchner
jenniferkirchner@mhd.com214-947-4459
PRINCIPAL_INVESTIGATORAlejandro Mejia, M.D.

The Liver Institute, Methodist Dallas Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026